Sovran Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378K Buy
+2,173
New +$553K 0.03% 440

Other funds holding ALNY

Sovran Advisors's ALNY Position: Q3 2026 in Review

Sovran Advisors opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 2,173 shares worth $378K. The stake represents 0.03% of the portfolio and ranks #440 among its holdings.

727 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Sovran Advisors held 2,173 shares of Alnylam Pharmaceuticals worth $378K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new Sovran Advisors position in Q3 2026.
  • Alnylam Pharmaceuticals made up 0.03% of Sovran Advisors's portfolio in Q3 2026, its #440 holding.
  • 727 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Sovran Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.